Institute for Applied Cancer Science

The Institute for Applied Cancer Science (IACS) is a fully integrated drug discovery and development unit embedded within MD Anderson. By housing an innovative drug development operation within the world’s leading cancer center, we are surrounded by the culture of innovative academic science and clinical excellence for which MD Anderson is known. 

Our mission is to transform cancer care through the discovery and deployment of impactful new drugs to eliminate cancer. We are particularly focused on rare cancers and cancers for which no effective treatment currently exists.

IACS’ synergistic approach relies on three key components:

  •  A highly experienced team of professional drug discovery and development scientists;
  • Real-time access to insights gained by the best physician-scientists in the nation, who treat more than 120,000 cancer patients each year; and
  • Clinically informed, patient-oriented research programs that are focused on delivering impactful results to patients.